ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Small molecule metabolites: discovery of biomarkers and therapeutic targets

Qiu, Shi; Cai, Ying; Yao, Hong; Lin, Chunsheng; Xie, Yiqiang*; Tang, Songqi*; Zhang, Aihua*哈尔滨医科大学; 海南医学院; 1
Signal Transduction and Targeted Therapy2023-3-20DOI: 10.1038/s41392-023-01399-3
38被引12阅读
引用收藏
分享

摘要

Metabolic abnormalities lead to the dysfunction of metabolic pathways and metabolite accumulation or deficiency which is well-recognized hallmarks of diseases. Metabolite signatures that have close proximity to subject's phenotypic informative dimension, are useful for predicting diagnosis and prognosis of diseases as well as monitoring treatments. The lack of early biomarkers could lead to poor diagnosis and serious outcomes. Therefore, noninvasive diagnosis and monitoring methods with high specificity and selectivity are desperately needed. Small molecule metabolites-based metabolomics has become a specialized tool for metabolic biomarker and pathway analysis, for revealing possible mechanisms of human various diseases and deciphering therapeutic potentials. It could help identify functional biomarkers related to phenotypic variation and delineate biochemical pathways changes as early indicators of pathological dysfunction and damage prior to disease development. Recently, scientists have established a large number of metabolic profiles to reveal the underlying mechanisms and metabolic networks for therapeutic target exploration in biomedicine. This review summarized the metabolic analysis on the potential value of small-molecule candidate metabolites as biomarkers with clinical events, which may lead to better diagnosis, prognosis, drug screening and treatment. We also discuss challenges that need to be addressed to fuel the next wave of breakthroughs.

学科与关键词

关键词
SQUAMOUS-CELL CARCINOMASPECTROMETRY-BASED METABOLOMICSHIGH-THROUGHPUT METABOLOMICSMILD COGNITIVE IMPAIRMENTFLIGHT MASS-SPECTROMETRYGUT MICROBIOTALIQUID-CHROMATOGRAPHYMULTI-OMICSCARDIOVASCULAR-DISEASEPOTENTIAL BIOMARKERS
相关
加载中…
  • Metabolomics toward personalized medicine
    Jacob, Minnie; Lopata, Andreas L.; Dasouki, Majed; Rahman, Anas M. Abdel*Mass Spectrometry Reviews, 2019, 38(3): 221-238.被引 236
  • The role of metabolites and metabolomics in clinically applicable biomarkers of disease
    Mamas, Mamas; Dunn, Warwick B.; Neyses, Ludwig; Goodacre, Royston*Archives of Toxicology, 2011, 85(1): 5-17.被引 275
  • Metabolomics in the study of kidney diseases
    Weiss, Robert H.*; Kim, KyoungmiNATURE REVIEWS NEPHROLOGY, 2012, 8(1): 22-33.被引 211
查看全部 →

发表信息

论文状态
公开发表
期刊
Signal Transduction and Targeted Therapy
发表日期
2023-03-20
卷期
第 8 卷, 第 1 期
页码
132
DOI
10.1038/s41392-023-01399-3
期刊收录
CAST-L
成果收录
SCIE
资助标注
Program of Natural Science Foundation of State [81973745, 82104733, 81302905]; Talent Lift Engineering Project of China Association of TCM [QNRC2-B06]; Natural Science Foundation of Heilongjiang Province [YQ2019H030]

作者

  • Q

    Qiu, Shi (第一作者)

    hainan med univ

  • C

    Cai, Ying

    heilongjiang univ chinese med

查看全部 7 位作者收起作者
  • Y

    Yao, Hong

    1 · harbin med univ

  • L

    Lin, Chunsheng

    2 · heilongjiang univ chinese med

  • X

    Xie, Yiqiang (通讯)

    hainan med univ

  • T

    Tang, Songqi (通讯)

    hainan med univ

  • Z

    Zhang, Aihua (通讯)

    heilongjiang univ chinese med · hainan med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417